<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE rdf:RDF [
	<!ENTITY cmns-av "https://www.omg.org/spec/Commons/AnnotationVocabulary/">
	<!ENTITY cmns-cds "https://www.omg.org/spec/Commons/CodesAndCodeSets/">
	<!ENTITY cmns-cls "https://www.omg.org/spec/Commons/Classifiers/">
	<!ENTITY cmns-cmp "https://www.omg.org/spec/Commons/Composites/">
	<!ENTITY cmns-col "https://www.omg.org/spec/Commons/Collections/">
	<!ENTITY cmns-cxtdsg "https://www.omg.org/spec/Commons/ContextualDesignators/">
	<!ENTITY cmns-doc "https://www.omg.org/spec/Commons/Documents/">
	<!ENTITY cmns-dsg "https://www.omg.org/spec/Commons/Designators/">
	<!ENTITY cmns-ge-euj "https://www.omg.org/spec/Commons/EuropeanJurisdiction/EUGovernmentEntitiesAndJurisdictions/">
	<!ENTITY cmns-id "https://www.omg.org/spec/Commons/Identifiers/">
	<!ENTITY cmns-org "https://www.omg.org/spec/Commons/Organizations/">
	<!ENTITY cmns-prd "https://www.omg.org/spec/Commons/ProductsAndServices/">
	<!ENTITY cmns-pts "https://www.omg.org/spec/Commons/PartiesAndSituations/">
	<!ENTITY cmns-qtu "https://www.omg.org/spec/Commons/QuantitiesAndUnits/">
	<!ENTITY cmns-ra "https://www.omg.org/spec/Commons/RegistrationAuthorities/">
	<!ENTITY cmns-rga "https://www.omg.org/spec/Commons/RegulatoryAgencies/">
	<!ENTITY cmns-strcol "https://www.omg.org/spec/Commons/StructuredCollections/">
	<!ENTITY cmns-txt "https://www.omg.org/spec/Commons/TextDatatype/">
	<!ENTITY dct "http://purl.org/dc/terms/">
	<!ENTITY doc-ema "https://www.ema.europa.eu/en/documents/product-information/pluvicto-epar-product-information_en.pdf#">
	<!ENTITY doco "http://purl.org/spar/doco/">
	<!ENTITY idmp-chg "https://spec.pistoiaalliance.org/idmp/ontology/META/ChangeManagement/">
	<!ENTITY idmp-ctcae "https://spec.pistoiaalliance.org/idmp/ontology/ISO/NorthAmericanJurisdiction/CommonTerminologyCriteriaForAdverseEvents/">
	<!ENTITY idmp-doco "https://spec.pistoiaalliance.org/idmp/ontology/EXT/Extensions/DocumentComponents/">
	<!ENTITY idmp-dtp "https://spec.pistoiaalliance.org/idmp/ontology/ISO/ISO21090-HarmonizedDatatypes/">
	<!ENTITY idmp-eura "https://spec.pistoiaalliance.org/idmp/ontology/ISO/EuropeanJurisdiction/EuropeanRegistrationAuthorities/">
	<!ENTITY idmp-eurga "https://spec.pistoiaalliance.org/idmp/ontology/ISO/EuropeanJurisdiction/EuropeanRegulatoryAgencies/">
	<!ENTITY idmp-meddra "https://spec.pistoiaalliance.org/idmp/ontology/ISO/MedicalDictionaryForRegulatoryActivities/">
	<!ENTITY idmp-mprd "https://spec.pistoiaalliance.org/idmp/ontology/ISO/ISO11615-MedicinalProducts/">
	<!ENTITY idmp-nara "https://spec.pistoiaalliance.org/idmp/ontology/ISO/NorthAmericanJurisdiction/NorthAmericanRegistrationAuthorities/">
	<!ENTITY idmp-narga "https://spec.pistoiaalliance.org/idmp/ontology/ISO/NorthAmericanJurisdiction/NorthAmericanRegulatoryAgencies/">
	<!ENTITY idmp-phprd "https://spec.pistoiaalliance.org/idmp/ontology/ISO/ISO11616-PharmaceuticalProducts/">
	<!ENTITY idmp-plu "https://spec.pistoiaalliance.org/idmp/ontology/EXT/Examples/PluvictoExample/">
	<!ENTITY idmp-ra "https://spec.pistoiaalliance.org/idmp/ontology/ISO/ISO11238-RegistrationAuthorities/">
	<!ENTITY idmp-spor "https://spec.pistoiaalliance.org/idmp/ontology/ISO/EuropeanJurisdiction/SubstancesProductsOrganisationsReferentials/">
	<!ENTITY idmp-sub "https://spec.pistoiaalliance.org/idmp/ontology/ISO/ISO11238-Substances/">
	<!ENTITY idmp-ucum "https://spec.pistoiaalliance.org/idmp/ontology/EXT/Extensions/UnifiedCodeForUnitsOfMeasure/">
	<!ENTITY idmp-uom "https://spec.pistoiaalliance.org/idmp/ontology/ISO/ISO11240-UnitsOfMeasurement/">
	<!ENTITY lcc-3166-1 "https://www.omg.org/spec/LCC/Countries/ISO3166-1-CountryCodes/">
	<!ENTITY lcc-639-1 "https://www.omg.org/spec/LCC/Languages/ISO639-1-LanguageCodes/">
	<!ENTITY lcc-cr "https://www.omg.org/spec/LCC/Countries/CountryRepresentation/">
	<!ENTITY lcc-lr "https://www.omg.org/spec/LCC/Languages/LanguageRepresentation/">
	<!ENTITY mvf "https://www.omg.org/spec/MVF/MultipleVocabularyFacility/">
	<!ENTITY mvf-trm "https://www.omg.org/spec/MVF/ISO1087-VocabularyForTermsAndDefinitions/">
	<!ENTITY owl "http://www.w3.org/2002/07/owl#">
	<!ENTITY po "http://purl.org/spar/po/">
	<!ENTITY rdf "http://www.w3.org/1999/02/22-rdf-syntax-ns#">
	<!ENTITY rdfs "http://www.w3.org/2000/01/rdf-schema#">
	<!ENTITY skos "http://www.w3.org/2004/02/skos/core#">
	<!ENTITY xsd "http://www.w3.org/2001/XMLSchema#">
]>
<rdf:RDF xml:base="https://spec.pistoiaalliance.org/idmp/ontology/EXT/Examples/PluvictoExample-EMADocument/"
	xmlns:cmns-av="https://www.omg.org/spec/Commons/AnnotationVocabulary/"
	xmlns:cmns-cds="https://www.omg.org/spec/Commons/CodesAndCodeSets/"
	xmlns:cmns-cls="https://www.omg.org/spec/Commons/Classifiers/"
	xmlns:cmns-cmp="https://www.omg.org/spec/Commons/Composites/"
	xmlns:cmns-col="https://www.omg.org/spec/Commons/Collections/"
	xmlns:cmns-cxtdsg="https://www.omg.org/spec/Commons/ContextualDesignators/"
	xmlns:cmns-doc="https://www.omg.org/spec/Commons/Documents/"
	xmlns:cmns-dsg="https://www.omg.org/spec/Commons/Designators/"
	xmlns:cmns-ge-euj="https://www.omg.org/spec/Commons/EuropeanJurisdiction/EUGovernmentEntitiesAndJurisdictions/"
	xmlns:cmns-id="https://www.omg.org/spec/Commons/Identifiers/"
	xmlns:cmns-org="https://www.omg.org/spec/Commons/Organizations/"
	xmlns:cmns-prd="https://www.omg.org/spec/Commons/ProductsAndServices/"
	xmlns:cmns-pts="https://www.omg.org/spec/Commons/PartiesAndSituations/"
	xmlns:cmns-qtu="https://www.omg.org/spec/Commons/QuantitiesAndUnits/"
	xmlns:cmns-ra="https://www.omg.org/spec/Commons/RegistrationAuthorities/"
	xmlns:cmns-rga="https://www.omg.org/spec/Commons/RegulatoryAgencies/"
	xmlns:cmns-strcol="https://www.omg.org/spec/Commons/StructuredCollections/"
	xmlns:cmns-txt="https://www.omg.org/spec/Commons/TextDatatype/"
	xmlns:dct="http://purl.org/dc/terms/"
	xmlns:doc-ema="https://www.ema.europa.eu/en/documents/product-information/pluvicto-epar-product-information_en.pdf#"
	xmlns:doco="http://purl.org/spar/doco/"
	xmlns:idmp-chg="https://spec.pistoiaalliance.org/idmp/ontology/META/ChangeManagement/"
	xmlns:idmp-ctcae="https://spec.pistoiaalliance.org/idmp/ontology/ISO/NorthAmericanJurisdiction/CommonTerminologyCriteriaForAdverseEvents/"
	xmlns:idmp-doco="https://spec.pistoiaalliance.org/idmp/ontology/EXT/Extensions/DocumentComponents/"
	xmlns:idmp-dtp="https://spec.pistoiaalliance.org/idmp/ontology/ISO/ISO21090-HarmonizedDatatypes/"
	xmlns:idmp-eura="https://spec.pistoiaalliance.org/idmp/ontology/ISO/EuropeanJurisdiction/EuropeanRegistrationAuthorities/"
	xmlns:idmp-eurga="https://spec.pistoiaalliance.org/idmp/ontology/ISO/EuropeanJurisdiction/EuropeanRegulatoryAgencies/"
	xmlns:idmp-meddra="https://spec.pistoiaalliance.org/idmp/ontology/ISO/MedicalDictionaryForRegulatoryActivities/"
	xmlns:idmp-mprd="https://spec.pistoiaalliance.org/idmp/ontology/ISO/ISO11615-MedicinalProducts/"
	xmlns:idmp-nara="https://spec.pistoiaalliance.org/idmp/ontology/ISO/NorthAmericanJurisdiction/NorthAmericanRegistrationAuthorities/"
	xmlns:idmp-narga="https://spec.pistoiaalliance.org/idmp/ontology/ISO/NorthAmericanJurisdiction/NorthAmericanRegulatoryAgencies/"
	xmlns:idmp-phprd="https://spec.pistoiaalliance.org/idmp/ontology/ISO/ISO11616-PharmaceuticalProducts/"
	xmlns:idmp-plu="https://spec.pistoiaalliance.org/idmp/ontology/EXT/Examples/PluvictoExample/"
	xmlns:idmp-ra="https://spec.pistoiaalliance.org/idmp/ontology/ISO/ISO11238-RegistrationAuthorities/"
	xmlns:idmp-spor="https://spec.pistoiaalliance.org/idmp/ontology/ISO/EuropeanJurisdiction/SubstancesProductsOrganisationsReferentials/"
	xmlns:idmp-sub="https://spec.pistoiaalliance.org/idmp/ontology/ISO/ISO11238-Substances/"
	xmlns:idmp-ucum="https://spec.pistoiaalliance.org/idmp/ontology/EXT/Extensions/UnifiedCodeForUnitsOfMeasure/"
	xmlns:idmp-uom="https://spec.pistoiaalliance.org/idmp/ontology/ISO/ISO11240-UnitsOfMeasurement/"
	xmlns:lcc-3166-1="https://www.omg.org/spec/LCC/Countries/ISO3166-1-CountryCodes/"
	xmlns:lcc-639-1="https://www.omg.org/spec/LCC/Languages/ISO639-1-LanguageCodes/"
	xmlns:lcc-cr="https://www.omg.org/spec/LCC/Countries/CountryRepresentation/"
	xmlns:lcc-lr="https://www.omg.org/spec/LCC/Languages/LanguageRepresentation/"
	xmlns:mvf="https://www.omg.org/spec/MVF/MultipleVocabularyFacility/"
	xmlns:mvf-trm="https://www.omg.org/spec/MVF/ISO1087-VocabularyForTermsAndDefinitions/"
	xmlns:owl="http://www.w3.org/2002/07/owl#"
	xmlns:po="http://purl.org/spar/po/"
	xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
	xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
	xmlns:skos="http://www.w3.org/2004/02/skos/core#"
	xmlns:xsd="http://www.w3.org/2001/XMLSchema#">
	
	<owl:Ontology rdf:about="https://spec.pistoiaalliance.org/idmp/ontology/EXT/Examples/PluvictoExample-EMADocument/">
		<rdfs:label>Novartis&apos; PLUVICTOÂ® Example - EMA product characterstics document</rdfs:label>
		<dct:abstract>This ontology provides an example for some an external description of the PDF content of the product characteristics of Pluvicto, approved by EMA.</dct:abstract>
		<dct:license rdf:datatype="&xsd;anyURI">https://opensource.org/licenses/MIT</dct:license>
		<owl:imports rdf:resource="http://purl.org/spar/doco/"/>
		<owl:imports rdf:resource="http://purl.org/spar/po/"/>
		<owl:imports rdf:resource="https://spec.pistoiaalliance.org/idmp/ontology/EXT/Extensions/DocumentComponents/"/>
		<owl:imports rdf:resource="https://spec.pistoiaalliance.org/idmp/ontology/EXT/Extensions/UnifiedCodeForUnitsOfMeasure/"/>
		<owl:imports rdf:resource="https://www.omg.org/spec/Commons/AnnotationVocabulary/"/>
		<owl:imports rdf:resource="https://www.omg.org/spec/Commons/Classifiers/"/>
		<owl:imports rdf:resource="https://www.omg.org/spec/Commons/Collections/"/>
		<owl:imports rdf:resource="https://www.omg.org/spec/Commons/ContextualDesignators/"/>
		<owl:imports rdf:resource="https://www.omg.org/spec/Commons/Designators/"/>
		<owl:imports rdf:resource="https://www.omg.org/spec/Commons/Documents/"/>
		<owl:imports rdf:resource="https://www.omg.org/spec/Commons/EuropeanJurisdiction/EUGovernmentEntitiesAndJurisdictions/"/>
		<owl:imports rdf:resource="https://www.omg.org/spec/Commons/Identifiers/"/>
		<owl:imports rdf:resource="https://www.omg.org/spec/Commons/Organizations/"/>
		<owl:imports rdf:resource="https://www.omg.org/spec/Commons/PartiesAndSituations/"/>
		<owl:imports rdf:resource="https://www.omg.org/spec/Commons/ProductsAndServices/"/>
		<owl:imports rdf:resource="https://www.omg.org/spec/Commons/QuantitiesAndUnits/"/>
		<owl:imports rdf:resource="https://www.omg.org/spec/Commons/RegistrationAuthorities/"/>
		<owl:imports rdf:resource="https://www.omg.org/spec/Commons/RegulatoryAgencies/"/>
		<owl:imports rdf:resource="https://www.omg.org/spec/Commons/StructuredCollections/"/>
		<owl:imports rdf:resource="https://www.omg.org/spec/Commons/TextDatatype/"/>
		<owl:imports rdf:resource="https://www.omg.org/spec/LCC/Countries/CountryRepresentation/"/>
		<owl:imports rdf:resource="https://www.omg.org/spec/LCC/Countries/ISO3166-1-CountryCodes/"/>
		<owl:imports rdf:resource="https://www.omg.org/spec/LCC/Languages/ISO639-1-LanguageCodes/"/>
		<owl:imports rdf:resource="https://www.omg.org/spec/LCC/Languages/LanguageRepresentation/"/>
		<owl:versionIRI rdf:resource="https://spec.pistoiaalliance.org/idmp/ontology/EXT/20231001/Examples/PluvictoExample-EMADocument/"/>
		<idmp-chg:hasMaturityLevel rdf:resource="&idmp-chg;Informative"/>
		<cmns-av:copyright>Copyright (c) 2022-2023 EDM Council, Inc.</cmns-av:copyright>
		<cmns-av:copyright>Copyright (c) 2022-2023 Pistoia Alliance, Inc.</cmns-av:copyright>
		<cmns-av:usageNote>This example is for illustration purposes only. The data provided may not be up-to-date, and in some cases, &apos;dummy&apos; data has been included. The product information included here shall not be used for any other purpose than for educational purposes regarding the IDMP-O implementation.</cmns-av:usageNote>
	</owl:Ontology>
	
	<owl:NamedIndividual rdf:about="https://www.ema.europa.eu/en/documents/product-information/pluvicto-epar-product-information_en.pdf">
		<rdf:type rdf:resource="&cmns-doc;Document"/>
		<dct:format rdf:resource="http://www.iana.org/assignments/media-types/application/pdf"/>
		<dct:title>Pluvicto EPAR Product Information</dct:title>
		<po:contains rdf:resource="&doc-ema;Annex-1"/>
		<po:contains rdf:resource="&doc-ema;Annex-2"/>
		<po:contains rdf:resource="&doc-ema;Annex-3"/>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Annex-1">
		<rdf:type rdf:resource="&doco;Chapter"/>
		<po:contains rdf:resource="&doc-ema;Section-1"/>
		<po:contains rdf:resource="&doc-ema;Section-2"/>
		<po:contains rdf:resource="&doc-ema;Section-3"/>
		<po:contains rdf:resource="&doc-ema;Section-4"/>
		<po:contains rdf:resource="&doc-ema;Section-5"/>
		<po:contains rdf:resource="&doc-ema;Section-6"/>
		<po:containsAsHeader rdf:resource="&doc-ema;Annex-1-SubTitle"/>
		<po:containsAsHeader rdf:resource="&doc-ema;Annex-1-Title"/>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Annex-1-SubTitle">
		<rdf:type rdf:resource="&doco;ChapterSubtitle"/>
		<idmp-doco:hasText>SUMMARY OF PRODUCT CHARACTERISTICS</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Annex-1-Title">
		<rdf:type rdf:resource="&doco;ChapterTitle"/>
		<idmp-doco:hasText>ANNEX I</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Annex-2">
		<rdf:type rdf:resource="&doco;Chapter"/>
		<po:contains rdf:resource="&doc-ema;Annex-2"/>
		<po:containsAsHeader rdf:resource="&doc-ema;Annex-2-Title"/>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Annex-2-Title">
		<rdf:type rdf:resource="&doco;ChapterTitle"/>
		<idmp-doco:hasText>ANNEX II</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Annex-3">
		<rdf:type rdf:resource="&doco;Chapter"/>
		<po:contains rdf:resource="&doc-ema;Annex-3"/>
		<po:containsAsHeader rdf:resource="&doc-ema;Annex-3-SubTitle"/>
		<po:containsAsHeader rdf:resource="&doc-ema;Annex-3-Title"/>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Annex-3-SubTitle">
		<rdf:type rdf:resource="&doco;ChapterSubtitle"/>
		<idmp-doco:hasText>LABELLING AND PACKAGE LEAFLET</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Annex-3-Title">
		<rdf:type rdf:resource="&doco;ChapterTitle"/>
		<idmp-doco:hasText>ANNEX III</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Figure-1">
		<rdf:type rdf:resource="&doco;Figure"/>
		<idmp-doco:hasCaption rdf:resource="&doc-ema;Figure-1-Caption"/>
		<cmns-strcol:hasIndexValue>
			<cmns-strcol:IndexValue>
				<cmns-doc:refersTo rdf:resource="&doc-ema;Annex-1"/>
				<cmns-qtu:hasNumericValue rdf:datatype="&xsd;positiveInteger">1</cmns-qtu:hasNumericValue>
			</cmns-strcol:IndexValue>
		</cmns-strcol:hasIndexValue>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Figure-1-Box">
		<rdf:type rdf:resource="&doco;FigureBox"/>
		<dct:hasPart rdf:resource="&doc-ema;Figure-1"/>
		<dct:hasPart rdf:resource="&doc-ema;Figure-1-Label"/>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Figure-1-Caption">
		<rdf:type rdf:resource="&idmp-doco;FigureCaption"/>
		<idmp-doco:hasText>Kaplan-Meier plot of OS in VISION</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Figure-1-Label">
		<rdf:type rdf:resource="&doco;FigureLabel"/>
		<idmp-doco:hasText>Figure 1</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Figure-2">
		<rdf:type rdf:resource="&doco;Figure"/>
		<idmp-doco:hasCaption rdf:resource="&doc-ema;Figure-2-Caption"/>
		<cmns-strcol:hasIndexValue>
			<cmns-strcol:IndexValue>
				<cmns-doc:refersTo rdf:resource="&doc-ema;Annex-1"/>
				<cmns-qtu:hasNumericValue rdf:datatype="&xsd;positiveInteger">2</cmns-qtu:hasNumericValue>
			</cmns-strcol:IndexValue>
		</cmns-strcol:hasIndexValue>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Figure-2-Box">
		<rdf:type rdf:resource="&doco;FigureBox"/>
		<dct:hasPart rdf:resource="&doc-ema;Figure-2"/>
		<dct:hasPart rdf:resource="&doc-ema;Figure-2-Label"/>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Figure-2-Caption">
		<rdf:type rdf:resource="&idmp-doco;FigureCaption"/>
		<idmp-doco:hasText>Kaplan-Meier plot of BICR-assessed rPFS in VISION</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Figure-2-Label">
		<rdf:type rdf:resource="&doco;FigureLabel"/>
		<idmp-doco:hasText>Figure 2</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-1">
		<rdf:type rdf:resource="&doco;Section"/>
		<po:contains rdf:resource="&doc-ema;Section-1-Text"/>
		<po:containsAsHeader rdf:resource="&doc-ema;Section-1-Title"/>
		<cmns-strcol:hasIndexValue>
			<cmns-strcol:IndexValue>
				<cmns-doc:refersTo rdf:resource="&doc-ema;Annex-1"/>
				<cmns-qtu:hasNumericValue rdf:datatype="&xsd;positiveInteger">1</cmns-qtu:hasNumericValue>
			</cmns-strcol:IndexValue>
		</cmns-strcol:hasIndexValue>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-1-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Pluvicto 1 000 MBq/mL solution for injection/infusion</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-1-Title">
		<rdf:type rdf:resource="&doco;SectionTitle"/>
		<idmp-doco:hasText>NAME OF THE MEDICINAL PRODUCT</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-2">
		<rdf:type rdf:resource="&doco;Section"/>
		<po:contains rdf:resource="&doc-ema;Section-2-ExcipientWithKnownEffect"/>
		<po:contains rdf:resource="&doc-ema;Section-2-PhysicalCharacteristics"/>
		<po:contains rdf:resource="&doc-ema;Section-2-Text"/>
		<po:containsAsHeader rdf:resource="&doc-ema;Section-2-Title"/>
		<cmns-strcol:hasIndexValue>
			<cmns-strcol:IndexValue>
				<cmns-doc:refersTo rdf:resource="&doc-ema;Annex-1"/>
				<cmns-qtu:hasNumericValue rdf:datatype="&xsd;positiveInteger">2</cmns-qtu:hasNumericValue>
			</cmns-strcol:IndexValue>
		</cmns-strcol:hasIndexValue>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-2-ExcipientWithKnownEffect">
		<rdf:type rdf:resource="&doco;Section"/>
		<po:contains rdf:resource="&doc-ema;Section-2-ExcipientWithKnownEffect-Text"/>
		<po:containsAsHeader rdf:resource="&doc-ema;Section-2-ExcipientWithKnownEffect-Title"/>
		<cmns-strcol:hasIndexValue>
			<cmns-strcol:IndexValue>
				<cmns-doc:refersTo rdf:resource="&doc-ema;Section-2"/>
				<cmns-qtu:hasNumericValue rdf:datatype="&xsd;positiveInteger">2</cmns-qtu:hasNumericValue>
			</cmns-strcol:IndexValue>
		</cmns-strcol:hasIndexValue>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-2-ExcipientWithKnownEffect-Text">
		<rdf:type rdf:resource="&doco;SectionTitle"/>
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Each mL of solution contains up to 0.312 mmol (7.1 mg) of sodium. Each vial contains up to
88.75 mg of sodium.
For the full list of excipients, see section 6.1.</idmp-doco:hasText>
		<idmp-doco:hasText>Excipient with known effect</idmp-doco:hasText>
		<cmns-doc:refersTo rdf:resource="&doc-ema;Section-6.1"/>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-2-PhysicalCharacteristics">
		<rdf:type rdf:resource="&doco;Section"/>
		<po:contains rdf:resource="&doc-ema;Section-2-PhysicalCharacteristics-Text"/>
		<po:containsAsHeader rdf:resource="&doc-ema;Section-2-PhysicalCharacteristics-Title"/>
		<cmns-strcol:hasIndexValue>
			<cmns-strcol:IndexValue>
				<cmns-doc:refersTo rdf:resource="&doc-ema;Section-2"/>
				<cmns-qtu:hasNumericValue rdf:datatype="&xsd;positiveInteger">1</cmns-qtu:hasNumericValue>
			</cmns-strcol:IndexValue>
		</cmns-strcol:hasIndexValue>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-2-PhysicalCharacteristics-Text">
		<rdf:type rdf:resource="&doco;SectionTitle"/>
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Lutetium-177 decays to a stable hafnium-177 with a physical half-life of 6.647 days by emitting
beta-minus radiation with a maximum energy of 0.498 MeV (79%) and photon radiation (Î³) of
0.208 MeV (11%) and 0.113 MeV (6.4%).</idmp-doco:hasText>
		<idmp-doco:hasText>Physical characteristics</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-2-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>One mL of solution contains 1 000 MBq of lutetium (177Lu) vipivotide tetraxetan at the date and time
of calibration.
The total amount of radioactivity per single-dose vial is 7 400 MBq Â± 10% at the date and time of
administration. Given the fixed volumetric activity of 1 000 MBq/mL at the date and time of
calibration, the volume of the solution in the vial can range from 7.5 mL to 12.5 mL in order to
provide the required amount of radioactivity at the date and time of administration.</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-2-Title">
		<rdf:type rdf:resource="&doco;SectionTitle"/>
		<idmp-doco:hasText>QUALITATIVE AND QUANTITATIVE COMPOSITION</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-3">
		<rdf:type rdf:resource="&doco;Section"/>
		<po:contains rdf:resource="&doc-ema;Section-3-Text"/>
		<po:containsAsHeader rdf:resource="&doc-ema;Section-3-Title"/>
		<cmns-strcol:hasIndexValue>
			<cmns-strcol:IndexValue>
				<cmns-doc:refersTo rdf:resource="&doc-ema;Annex-1"/>
				<cmns-qtu:hasNumericValue rdf:datatype="&xsd;positiveInteger">3</cmns-qtu:hasNumericValue>
			</cmns-strcol:IndexValue>
		</cmns-strcol:hasIndexValue>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-3-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Solution for injection/infusion.
Clear, colourless to slightly yellow solution, pH: 4.5 to 7.0.</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-3-Title">
		<rdf:type rdf:resource="&doco;SectionTitle"/>
		<idmp-doco:hasText>PHARMACEUTICAL FORM</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4">
		<rdf:type rdf:resource="&doco;Section"/>
		<po:contains rdf:resource="&doc-ema;Section-4.1"/>
		<po:contains rdf:resource="&doc-ema;Section-4.2"/>
		<po:contains rdf:resource="&doc-ema;Section-4.3"/>
		<po:contains rdf:resource="&doc-ema;Section-4.4"/>
		<po:contains rdf:resource="&doc-ema;Section-4.5"/>
		<po:contains rdf:resource="&doc-ema;Section-4.6"/>
		<po:contains rdf:resource="&doc-ema;Section-4.7"/>
		<po:contains rdf:resource="&doc-ema;Section-4.8"/>
		<po:contains rdf:resource="&doc-ema;Section-4.9"/>
		<po:containsAsHeader rdf:resource="&doc-ema;Section-4-Title"/>
		<cmns-strcol:hasIndexValue>
			<cmns-strcol:IndexValue>
				<cmns-doc:refersTo rdf:resource="&doc-ema;Annex-1"/>
				<cmns-qtu:hasNumericValue rdf:datatype="&xsd;positiveInteger">4</cmns-qtu:hasNumericValue>
			</cmns-strcol:IndexValue>
		</cmns-strcol:hasIndexValue>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4-Title">
		<rdf:type rdf:resource="&doco;SectionTitle"/>
		<idmp-doco:hasText>CLINICAL PARTICULARS</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.1">
		<rdf:type rdf:resource="&doco;Section"/>
		<po:contains rdf:resource="&doc-ema;Section-4.1-Text"/>
		<po:containsAsHeader rdf:resource="&doc-ema;Section-4.1-Title"/>
		<cmns-strcol:hasIndexValue>
			<cmns-strcol:IndexValue>
				<cmns-doc:refersTo rdf:resource="&doc-ema;Section-4"/>
				<cmns-qtu:hasNumericValue rdf:datatype="&xsd;positiveInteger">1</cmns-qtu:hasNumericValue>
			</cmns-strcol:IndexValue>
		</cmns-strcol:hasIndexValue>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.1-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Pluvicto in combination with androgen deprivation therapy (ADT) with or without androgen receptor
					(AR) pathway inhibition is indicated for the treatment of adult patients with progressive
					prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer
					(mCRPC) who have been treated with AR pathway inhibition and taxane-based chemotherapy (see
					section 5.1).</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.1-Title">
		<rdf:type rdf:resource="&doco;SectionTitle"/>
		<idmp-doco:hasText>Therapeutic indications</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.2">
		<rdf:type rdf:resource="&doco;Section"/>
		<po:contains rdf:resource="&doc-ema;Section-4.2-ImportantSafetyInstructions"/>
		<po:contains rdf:resource="&doc-ema;Section-4.2-MethodOfAdministration"/>
		<po:contains rdf:resource="&doc-ema;Section-4.2-PatientIdentification"/>
		<po:contains rdf:resource="&doc-ema;Section-4.2-Posology"/>
		<po:containsAsHeader rdf:resource="&doc-ema;Section-4.2-Title"/>
		<cmns-strcol:hasIndexValue>
			<cmns-strcol:IndexValue>
				<cmns-doc:refersTo rdf:resource="&doc-ema;Section-4"/>
				<cmns-qtu:hasNumericValue rdf:datatype="&xsd;positiveInteger">2</cmns-qtu:hasNumericValue>
			</cmns-strcol:IndexValue>
		</cmns-strcol:hasIndexValue>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.2-ImportantSafetyInstructions">
		<rdf:type rdf:resource="&doco;Section"/>
		<po:contains rdf:resource="&doc-ema;Section-4.2-ImportantSafetyInstructions-Paragraph-1"/>
		<po:contains rdf:resource="&doc-ema;Section-4.2-ImportantSafetyInstructions-Paragraph-2"/>
		<po:containsAsHeader rdf:resource="&doc-ema;Section-4.2-ImportantSafetyInstructions-Title"/>
		<cmns-strcol:hasIndexValue>
			<cmns-strcol:IndexValue>
				<cmns-doc:refersTo rdf:resource="&doc-ema;Section-4.2"/>
				<cmns-qtu:hasNumericValue rdf:datatype="&xsd;positiveInteger">1</cmns-qtu:hasNumericValue>
			</cmns-strcol:IndexValue>
		</cmns-strcol:hasIndexValue>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.2-ImportantSafetyInstructions-Paragraph-1">
		<rdf:type rdf:resource="&doco;Paragraph"/>
		<po:contains rdf:resource="&doc-ema;Section-4.2-ImportantSafetyInstructions-Paragraph-1-Text"/>
		<cmns-strcol:hasIndexValue>
			<cmns-strcol:IndexValue>
				<cmns-doc:refersTo rdf:resource="&doc-ema;Section-4.2-ImportantSafetyInstructions"/>
				<cmns-qtu:hasNumericValue rdf:datatype="&xsd;positiveInteger">1</cmns-qtu:hasNumericValue>
			</cmns-strcol:IndexValue>
		</cmns-strcol:hasIndexValue>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.2-ImportantSafetyInstructions-Paragraph-1-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Pluvicto should be administered only by persons authorised to handle radiopharmaceuticals in 
designated clinical settings (see section 6.6) and after evaluation of the patient by a qualified
physician.</idmp-doco:hasText>
		<cmns-doc:refersTo rdf:resource="&doc-ema;Section-6.6"/>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.2-ImportantSafetyInstructions-Paragraph-2">
		<rdf:type rdf:resource="&doco;Paragraph"/>
		<po:contains rdf:resource="&doc-ema;Section-4.2-ImportantSafetyInstructions-Paragraph-2-Text"/>
		<cmns-strcol:hasIndexValue>
			<cmns-strcol:IndexValue>
				<cmns-doc:refersTo rdf:resource="&doc-ema;Section-4.2-ImportantSafetyInstructions"/>
				<cmns-qtu:hasNumericValue rdf:datatype="&xsd;positiveInteger">2</cmns-qtu:hasNumericValue>
			</cmns-strcol:IndexValue>
		</cmns-strcol:hasIndexValue>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.2-ImportantSafetyInstructions-Paragraph-2-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Radiopharmaceuticals, including Pluvicto, should be used by or under the control of healthcare
professionals who are qualified by specific training and experience in the safe use and handling of
radiopharmaceuticals, and whose experience and training have been approved by the appropriate
governmental agency authorised to license the use of radiopharmaceuticals.</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.2-ImportantSafetyInstructions-Title">
		<rdf:type rdf:resource="&doco;SectionTitle"/>
		<idmp-doco:hasText>Important safety instructions</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.2-MethodOfAdministration">
		<rdf:type rdf:resource="&doco;Section"/>
		<po:contains rdf:resource="&doc-ema;Section-4.2-MethodOfAdministration-AdministrationInstructions"/>
		<cmns-strcol:hasIndexValue>
			<cmns-strcol:IndexValue>
				<cmns-doc:refersTo rdf:resource="&doc-ema;Section-4.2"/>
				<cmns-qtu:hasNumericValue rdf:datatype="&xsd;positiveInteger">4</cmns-qtu:hasNumericValue>
			</cmns-strcol:IndexValue>
		</cmns-strcol:hasIndexValue>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.2-PatientIdentification">
		<rdf:type rdf:resource="&doco;Section"/>
		<po:containsAsHeader rdf:resource="&doc-ema;Section-4.2-PatientIdentification-Text"/>
		<cmns-strcol:hasIndexValue>
			<cmns-strcol:IndexValue>
				<cmns-doc:refersTo rdf:resource="&doc-ema;Section-4.2"/>
				<cmns-qtu:hasNumericValue rdf:datatype="&xsd;positiveInteger">2</cmns-qtu:hasNumericValue>
			</cmns-strcol:IndexValue>
		</cmns-strcol:hasIndexValue>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.2-PatientIdentification-Text">
		<rdf:type rdf:resource="&doco;SectionTitle"/>
		<idmp-doco:hasText>Patient identification</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.2-Posology">
		<rdf:type rdf:resource="&doco;Section"/>
		<po:contains rdf:resource="&doc-ema;Section-4.2-Posology-DoseModificationForAdverseReactions"/>
		<po:contains rdf:resource="&doc-ema;Section-4.2-Posology-SpecialPopulations"/>
		<po:contains rdf:resource="&doc-ema;Section-4.2-Posology-TreatmentMonitoring"/>
		<po:containsAsHeader rdf:resource="&doc-ema;Section-4.2-Posology-Text"/>
		<cmns-strcol:hasIndexValue>
			<cmns-strcol:IndexValue>
				<cmns-doc:refersTo rdf:resource="&doc-ema;Section-4.2"/>
				<cmns-qtu:hasNumericValue rdf:datatype="&xsd;positiveInteger">3</cmns-qtu:hasNumericValue>
			</cmns-strcol:IndexValue>
		</cmns-strcol:hasIndexValue>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.2-Posology-DoseModificationForAdverseReactions">
		<rdf:type rdf:resource="&doco;Section"/>
		<po:contains rdf:resource="&doc-ema;Table-1"/>
		<po:containsAsHeader rdf:resource="&doc-ema;Section-4.2-Posology-DoseModificationForAdverseReactions-Text"/>
		<cmns-strcol:hasIndexValue>
			<cmns-strcol:IndexValue>
				<cmns-doc:refersTo rdf:resource="&doc-ema;Section-4.2-Posology"/>
				<cmns-qtu:hasNumericValue rdf:datatype="&xsd;positiveInteger">2</cmns-qtu:hasNumericValue>
			</cmns-strcol:IndexValue>
		</cmns-strcol:hasIndexValue>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.2-Posology-DoseModificationForAdverseReactions-Text">
		<rdf:type rdf:resource="&doco;SectionTitle"/>
		<idmp-doco:hasText>Dose modifications for adverse reactions</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.2-Posology-SpecialPopulations">
		<rdf:type rdf:resource="&doco;Section"/>
		<po:containsAsHeader rdf:resource="&doc-ema;Section-4.2-Posology-SpecialPopulations-Text"/>
		<cmns-strcol:hasIndexValue>
			<cmns-strcol:IndexValue>
				<cmns-doc:refersTo rdf:resource="&doc-ema;Section-4.2-Posology"/>
				<cmns-qtu:hasNumericValue rdf:datatype="&xsd;positiveInteger">3</cmns-qtu:hasNumericValue>
			</cmns-strcol:IndexValue>
		</cmns-strcol:hasIndexValue>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.2-Posology-SpecialPopulations-Text">
		<rdf:type rdf:resource="&doco;SectionTitle"/>
		<idmp-doco:hasText>Special populations</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.2-Posology-Text">
		<rdf:type rdf:resource="&doco;SectionTitle"/>
		<idmp-doco:hasText>Posology</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.2-Posology-TreatmentMonitoring">
		<rdf:type rdf:resource="&doco;Section"/>
		<po:containsAsHeader rdf:resource="&doc-ema;Section-4.2-Posology-TreatmentMonitoring-Text"/>
		<cmns-strcol:hasIndexValue>
			<cmns-strcol:IndexValue>
				<cmns-doc:refersTo rdf:resource="&doc-ema;Section-4.2-Posology"/>
				<cmns-qtu:hasNumericValue rdf:datatype="&xsd;positiveInteger">1</cmns-qtu:hasNumericValue>
			</cmns-strcol:IndexValue>
		</cmns-strcol:hasIndexValue>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.2-Posology-TreatmentMonitoring-Text">
		<rdf:type rdf:resource="&doco;SectionTitle"/>
		<idmp-doco:hasText>Treatment monitoring</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.2-Title">
		<rdf:type rdf:resource="&doco;SectionTitle"/>
		<idmp-doco:hasText>Posology and method of administration</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.3">
		<rdf:type rdf:resource="&doco;Section"/>
		<po:contains rdf:resource="&doc-ema;Section-4.3-Text"/>
		<po:containsAsHeader rdf:resource="&doc-ema;Section-4.3-Title"/>
		<cmns-strcol:hasIndexValue>
			<cmns-strcol:IndexValue>
				<cmns-doc:refersTo rdf:resource="&doc-ema;Section-4"/>
				<cmns-qtu:hasNumericValue rdf:datatype="&xsd;positiveInteger">3</cmns-qtu:hasNumericValue>
			</cmns-strcol:IndexValue>
		</cmns-strcol:hasIndexValue>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.3-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.</idmp-doco:hasText>
		<cmns-doc:refersTo rdf:resource="&doc-ema;Section-6.1"/>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.3-Title">
		<rdf:type rdf:resource="&doco;SectionTitle"/>
		<idmp-doco:hasText>Contraindications</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.4">
		<rdf:type rdf:resource="&doco;Section"/>
		<po:contains rdf:resource="&doc-ema;Section-4.4-ContraceptionInMales"/>
		<po:contains rdf:resource="&doc-ema;Section-4.4-Fertility"/>
		<po:contains rdf:resource="&doc-ema;Section-4.4-IndividualBenefitRiskJustification"/>
		<po:contains rdf:resource="&doc-ema;Section-4.4-Myelosuppression"/>
		<po:contains rdf:resource="&doc-ema;Section-4.4-RenalHepaticImpairment"/>
		<po:contains rdf:resource="&doc-ema;Section-4.4-RenalToxicity"/>
		<po:contains rdf:resource="&doc-ema;Section-4.4-RiskFromRadiationExposure"/>
		<po:contains rdf:resource="&doc-ema;Section-4.4-SpecificWarnings"/>
		<po:containsAsHeader rdf:resource="&doc-ema;Section-4.4-Title"/>
		<cmns-strcol:hasIndexValue>
			<cmns-strcol:IndexValue>
				<cmns-doc:refersTo rdf:resource="&doc-ema;Section-4"/>
				<cmns-qtu:hasNumericValue rdf:datatype="&xsd;positiveInteger">4</cmns-qtu:hasNumericValue>
			</cmns-strcol:IndexValue>
		</cmns-strcol:hasIndexValue>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.4-Title">
		<rdf:type rdf:resource="&doco;SectionTitle"/>
		<idmp-doco:hasText>Special warnings and precautions for use</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.5">
		<rdf:type rdf:resource="&doco;Section"/>
		<po:contains rdf:resource="&doc-ema;Section-4.5-Text"/>
		<po:containsAsHeader rdf:resource="&doc-ema;Section-4.5-Title"/>
		<cmns-strcol:hasIndexValue>
			<cmns-strcol:IndexValue>
				<cmns-doc:refersTo rdf:resource="&doc-ema;Section-4"/>
				<cmns-qtu:hasNumericValue rdf:datatype="&xsd;positiveInteger">5</cmns-qtu:hasNumericValue>
			</cmns-strcol:IndexValue>
		</cmns-strcol:hasIndexValue>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.5-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>No clinical drug interaction studies were performed.</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.5-Title">
		<rdf:type rdf:resource="&doco;SectionTitle"/>
		<idmp-doco:hasText>Interaction with other medicinal products and other forms of interaction</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.6">
		<rdf:type rdf:resource="&doco;Section"/>
		<po:contains rdf:resource="&doc-ema;Section-4.6-BreastFeeding"/>
		<po:contains rdf:resource="&doc-ema;Section-4.6-ContraceptionInMales"/>
		<po:contains rdf:resource="&doc-ema;Section-4.6-Fertility"/>
		<po:contains rdf:resource="&doc-ema;Section-4.6-Pregnancy"/>
		<po:containsAsHeader rdf:resource="&doc-ema;Section-4.6-Title"/>
		<cmns-strcol:hasIndexValue>
			<cmns-strcol:IndexValue>
				<cmns-doc:refersTo rdf:resource="&doc-ema;Section-4"/>
				<cmns-qtu:hasNumericValue rdf:datatype="&xsd;positiveInteger">6</cmns-qtu:hasNumericValue>
			</cmns-strcol:IndexValue>
		</cmns-strcol:hasIndexValue>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.6-Title">
		<rdf:type rdf:resource="&doco;SectionTitle"/>
		<idmp-doco:hasText>Fertility, pregnancy and lactation</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.7">
		<rdf:type rdf:resource="&doco;Section"/>
		<po:contains rdf:resource="&doc-ema;Section-4.7-Text"/>
		<po:containsAsHeader rdf:resource="&doc-ema;Section-4.7-Title"/>
		<cmns-strcol:hasIndexValue>
			<cmns-strcol:IndexValue>
				<cmns-doc:refersTo rdf:resource="&doc-ema;Section-4"/>
				<cmns-qtu:hasNumericValue rdf:datatype="&xsd;positiveInteger">7</cmns-qtu:hasNumericValue>
			</cmns-strcol:IndexValue>
		</cmns-strcol:hasIndexValue>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.7-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Pluvicto may have a minor influence on the ability to drive and use machines.</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.7-Title">
		<rdf:type rdf:resource="&doco;SectionTitle"/>
		<idmp-doco:hasText>Effects on ability to drive and use machines</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.8">
		<rdf:type rdf:resource="&doco;Section"/>
		<po:contains rdf:resource="&doc-ema;Section-4.8-DescriptionOfSelectedAdverseReactions"/>
		<po:contains rdf:resource="&doc-ema;Section-4.8-SummaryOfSafetyProfile"/>
		<po:contains rdf:resource="&doc-ema;Section-4.8-TabulatedListOfAdverseReactions"/>
		<po:containsAsHeader rdf:resource="&doc-ema;Section-4.8-Title"/>
		<cmns-strcol:hasIndexValue>
			<cmns-strcol:IndexValue>
				<cmns-doc:refersTo rdf:resource="&doc-ema;Section-4"/>
				<cmns-qtu:hasNumericValue rdf:datatype="&xsd;positiveInteger">8</cmns-qtu:hasNumericValue>
			</cmns-strcol:IndexValue>
		</cmns-strcol:hasIndexValue>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.8-DescriptionOfSelectedAdverseReactions">
		<rdf:type rdf:resource="&doco;Section"/>
		<po:contains rdf:resource="&doc-ema;Section-4.8-DescriptionOfSelectedAdverseReactions-Myelosuppression"/>
		<po:contains rdf:resource="&doc-ema;Section-4.8-DescriptionOfSelectedAdverseReactions-RenalToxicity"/>
		<po:contains rdf:resource="&doc-ema;Section-4.8-DescriptionOfSelectedAdverseReactions-ReportingOfSuspectedAdverseReactions"/>
		<po:contains rdf:resource="&doc-ema;Section-4.8-DescriptionOfSelectedAdverseReactions-SecondPrimaryMalignancies"/>
		<po:containsAsHeader rdf:resource="&doc-ema;Section-4.8-DescriptionOfSelectedAdverseReactions-Title"/>
		<cmns-strcol:hasIndexValue>
			<cmns-strcol:IndexValue>
				<cmns-doc:refersTo rdf:resource="&doc-ema;Section-4.8"/>
				<cmns-qtu:hasNumericValue rdf:datatype="&xsd;positiveInteger">3</cmns-qtu:hasNumericValue>
			</cmns-strcol:IndexValue>
		</cmns-strcol:hasIndexValue>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.8-DescriptionOfSelectedAdverseReactions-Myelosuppression">
		<rdf:type rdf:resource="&doco;Section"/>
		<po:contains rdf:resource="&doc-ema;Section-4.8-DescriptionOfSelectedAdverseReactions-Myelosuppression-Paragraph-1"/>
		<po:contains rdf:resource="&doc-ema;Section-4.8-DescriptionOfSelectedAdverseReactions-Myelosuppression-Paragraph-2"/>
		<po:containsAsHeader rdf:resource="&doc-ema;Section-4.8-DescriptionOfSelectedAdverseReactions-Myelosuppression-Title"/>
		<cmns-strcol:hasIndexValue>
			<cmns-strcol:IndexValue>
				<cmns-doc:refersTo rdf:resource="&doc-ema;Section-4.8-DescriptionOfSelectedAdverseReactions"/>
				<cmns-qtu:hasNumericValue rdf:datatype="&xsd;positiveInteger">1</cmns-qtu:hasNumericValue>
			</cmns-strcol:IndexValue>
		</cmns-strcol:hasIndexValue>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.8-DescriptionOfSelectedAdverseReactions-Myelosuppression-Paragraph-1">
		<rdf:type rdf:resource="&doco;Paragraph"/>
		<po:contains rdf:resource="&doc-ema;Section-4.8-DescriptionOfSelectedAdverseReactions-Myelosuppression-Paragraph-1-Text"/>
		<cmns-strcol:hasIndexValue>
			<cmns-strcol:IndexValue>
				<cmns-doc:refersTo rdf:resource="&doc-ema;Section-4.8-DescriptionOfSelectedAdverseReactions-Myelosuppression"/>
				<cmns-qtu:hasNumericValue rdf:datatype="&xsd;positiveInteger">1</cmns-qtu:hasNumericValue>
			</cmns-strcol:IndexValue>
		</cmns-strcol:hasIndexValue>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.8-DescriptionOfSelectedAdverseReactions-Myelosuppression-Paragraph-1-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>In the VISION study, myelosuppression occurred more frequently in patients who received Pluvicto
plus BSoC compared to patients who received BSoC alone (all grades/grade â¥3): anaemia
(31.8%/12.9%) versus (13.2%/4.9%); thrombocytopenia (17.2%/7.9%) versus (4.4%/1.0%);
leukopenia (12.5%/2.5%) versus (2.0%/0.5%); lymphopenia (14.2%/7.8%) versus (3.9%/0.5%);
neutropenia (8.5%/3.4%) versus (1.5%/0.5%); pancytopenia (1.5%/1.1%) versus (0%/0%) including
two fatal events of pancytopenia in patients who received Pluvicto plus BSoC; and bicytopenia
(0.2%/0.2%) versus (0%/0%).</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.8-DescriptionOfSelectedAdverseReactions-Myelosuppression-Paragraph-2">
		<rdf:type rdf:resource="&doco;Paragraph"/>
		<po:contains rdf:resource="&doc-ema;Section-4.8-DescriptionOfSelectedAdverseReactions-Myelosuppression-Paragraph-2-Text"/>
		<cmns-strcol:hasIndexValue>
			<cmns-strcol:IndexValue>
				<cmns-doc:refersTo rdf:resource="&doc-ema;Section-4.8-DescriptionOfSelectedAdverseReactions-Myelosuppression"/>
				<cmns-qtu:hasNumericValue rdf:datatype="&xsd;positiveInteger">2</cmns-qtu:hasNumericValue>
			</cmns-strcol:IndexValue>
		</cmns-strcol:hasIndexValue>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.8-DescriptionOfSelectedAdverseReactions-Myelosuppression-Paragraph-2-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Myelosuppression adverse reactions that led to permanent discontinuation in â¥0.5% of patients who
received Pluvicto plus BSoC included: anaemia (2.8%), thrombocytopenia (2.8%), leukopenia (1.3%),
neutropenia (0.8%) and pancytopenia (0.6%). Myelosuppression adverse reactions that led to dose
interruptions/dose reductions in â¥0.5% of patients who received Pluvicto plus BSoC included:
anaemia (5.1%/1.3%), thrombocytopenia (3.6%/1.9%), leukopenia (1.5%/0.6%) and neutropenia
(0.8%/0.6%).</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.8-DescriptionOfSelectedAdverseReactions-Myelosuppression-Title">
		<rdf:type rdf:resource="&doco;SectionTitle"/>
		<idmp-doco:hasText>Myelosuppression</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.8-DescriptionOfSelectedAdverseReactions-RenalToxicity">
		<rdf:type rdf:resource="&doco;Section"/>
		<po:contains rdf:resource="&doc-ema;Section-4.8-DescriptionOfSelectedAdverseReactions-RenalToxicity-Paragraph-1"/>
		<po:contains rdf:resource="&doc-ema;Section-4.8-DescriptionOfSelectedAdverseReactions-RenalToxicity-Paragraph-2"/>
		<po:containsAsHeader rdf:resource="&doc-ema;Section-4.8-DescriptionOfSelectedAdverseReactions-RenalToxicity-Title"/>
		<cmns-strcol:hasIndexValue>
			<cmns-strcol:IndexValue>
				<cmns-doc:refersTo rdf:resource="&doc-ema;Section-4.8-DescriptionOfSelectedAdverseReactions"/>
				<cmns-qtu:hasNumericValue rdf:datatype="&xsd;positiveInteger">1</cmns-qtu:hasNumericValue>
			</cmns-strcol:IndexValue>
		</cmns-strcol:hasIndexValue>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.8-DescriptionOfSelectedAdverseReactions-RenalToxicity-Paragraph-1">
		<rdf:type rdf:resource="&doco;Paragraph"/>
		<po:contains rdf:resource="&doc-ema;Section-4.8-DescriptionOfSelectedAdverseReactions-RenalToxicity-Paragraph-1-Text"/>
		<cmns-strcol:hasIndexValue>
			<cmns-strcol:IndexValue>
				<cmns-doc:refersTo rdf:resource="&doc-ema;Section-4.8-DescriptionOfSelectedAdverseReactions-RenalToxicity"/>
				<cmns-qtu:hasNumericValue rdf:datatype="&xsd;positiveInteger">1</cmns-qtu:hasNumericValue>
			</cmns-strcol:IndexValue>
		</cmns-strcol:hasIndexValue>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.8-DescriptionOfSelectedAdverseReactions-RenalToxicity-Paragraph-1-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>In the VISION study, renal toxicity occurred more frequently in patients who received Pluvicto plus
BSoC compared to patients who received BSoC alone (all grades/grades 3 to 4): blood creatinine
increased (5.3%/0.2%) versus (2.4%/0.5%); acute kidney injury (3.6%/3.0%) versus (3.9%/2.4%);
renal failure (0.2%/0%) versus (0%/0%); and blood urea increased (0.2%/0%) versus (0%/0%).</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.8-DescriptionOfSelectedAdverseReactions-RenalToxicity-Paragraph-2">
		<rdf:type rdf:resource="&doco;Paragraph"/>
		<po:contains rdf:resource="&doc-ema;Section-4.8-DescriptionOfSelectedAdverseReactions-RenalToxicity-Paragraph-2-Text"/>
		<cmns-strcol:hasIndexValue>
			<cmns-strcol:IndexValue>
				<cmns-doc:refersTo rdf:resource="&doc-ema;Section-4.8-DescriptionOfSelectedAdverseReactions-RenalToxicity"/>
				<cmns-qtu:hasNumericValue rdf:datatype="&xsd;positiveInteger">2</cmns-qtu:hasNumericValue>
			</cmns-strcol:IndexValue>
		</cmns-strcol:hasIndexValue>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.8-DescriptionOfSelectedAdverseReactions-RenalToxicity-Paragraph-2-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Renal adverse reactions that led to permanent discontinuation in â¥0.2% of patients who received
Pluvicto plus BSoC included: blood creatinine increased (0.2%). Renal adverse reactions that led to
dose interruptions/dose reductions in â¥0.2% of patients who received Pluvicto plus BSoC included:
blood creatinine increased (0.2%/0.4%) and acute kidney injury (0.2%/0%).</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.8-DescriptionOfSelectedAdverseReactions-RenalToxicity-Title">
		<rdf:type rdf:resource="&doco;SectionTitle"/>
		<idmp-doco:hasText>Renal toxicity</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.8-DescriptionOfSelectedAdverseReactions-ReportingOfSuspectedAdverseReactions">
		<rdf:type rdf:resource="&doco;Section"/>
		<po:contains rdf:resource="&doc-ema;Section-4.8-DescriptionOfSelectedAdverseReactions-ReportingOfSuspectedAdverseReactions-Text"/>
		<po:containsAsHeader rdf:resource="&doc-ema;Section-4.8-DescriptionOfSelectedAdverseReactions-ReportingOfSuspectedAdverseReactions-Title"/>
		<cmns-strcol:hasIndexValue>
			<cmns-strcol:IndexValue>
				<cmns-doc:refersTo rdf:resource="&doc-ema;Section-4.8-DescriptionOfSelectedAdverseReactions"/>
				<cmns-qtu:hasNumericValue rdf:datatype="&xsd;positiveInteger">4</cmns-qtu:hasNumericValue>
			</cmns-strcol:IndexValue>
		</cmns-strcol:hasIndexValue>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.8-DescriptionOfSelectedAdverseReactions-ReportingOfSuspectedAdverseReactions-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Reporting suspected adverse reactions after authorisation of the medicinal product is important. It
allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare
professionals are asked to report any suspected adverse reactions via the national reporting system
listed in Appendix V.</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.8-DescriptionOfSelectedAdverseReactions-ReportingOfSuspectedAdverseReactions-Title">
		<rdf:type rdf:resource="&doco;SectionTitle"/>
		<idmp-doco:hasText>Reporting of suspected adverse reactions</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.8-DescriptionOfSelectedAdverseReactions-SecondPrimaryMalignancies">
		<rdf:type rdf:resource="&doco;Section"/>
		<po:contains rdf:resource="&doc-ema;Section-4.8-DescriptionOfSelectedAdverseReactions-SecondPrimaryMalignancies-Text"/>
		<po:containsAsHeader rdf:resource="&doc-ema;Section-4.8-DescriptionOfSelectedAdverseReactions-SecondPrimaryMalignancies-Title"/>
		<cmns-strcol:hasIndexValue>
			<cmns-strcol:IndexValue>
				<cmns-doc:refersTo rdf:resource="&doc-ema;Section-4.8-DescriptionOfSelectedAdverseReactions"/>
				<cmns-qtu:hasNumericValue rdf:datatype="&xsd;positiveInteger">3</cmns-qtu:hasNumericValue>
			</cmns-strcol:IndexValue>
		</cmns-strcol:hasIndexValue>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.8-DescriptionOfSelectedAdverseReactions-SecondPrimaryMalignancies-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Exposure to ionising radiation is linked with cancer induction and a potential for development of
hereditary defects. The radiation dose resulting from therapeutic exposure may result in higher
incidence of cancer and mutations. In all cases it is necessary to ensure that the risks of the radiation
are less than from the disease itself. As Pluvicto contributes to a patientâs overall long-term radiation
exposure, which is associated with an increased risk for cancer (see section 4.4), a potential risk of
second primary malignancies cannot be ruled out for radiopharmaceuticals such as Pluvicto. At the
time of the VISION primary analysis (cut-off date 27-Jan-2021), cases of squamous cell carcinoma
(4 patients; 0.8%) and basal cell carcinoma, malignant melanoma and squamous cell carcinoma of the
skin (1 patient each; 0.2% each) were reported in patients who received Pluvicto plus BSoC.</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.8-DescriptionOfSelectedAdverseReactions-SecondPrimaryMalignancies-Title">
		<rdf:type rdf:resource="&doco;SectionTitle"/>
		<idmp-doco:hasText>Second primary malignancies</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.8-DescriptionOfSelectedAdverseReactions-Title">
		<rdf:type rdf:resource="&doco;SectionTitle"/>
		<idmp-doco:hasText>Description of selected adverse reactions</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.8-SummaryOfSafetyProfile">
		<rdf:type rdf:resource="&doco;Section"/>
		<po:contains rdf:resource="&doc-ema;Section-4.8-SummaryOfSafetyProfile-Paragraph-1"/>
		<po:contains rdf:resource="&doc-ema;Section-4.8-SummaryOfSafetyProfile-Paragraph-2"/>
		<po:containsAsHeader rdf:resource="&doc-ema;Section-4.8-SummaryOfSafetyProfile-Title"/>
		<cmns-strcol:hasIndexValue>
			<cmns-strcol:IndexValue>
				<cmns-doc:refersTo rdf:resource="&doc-ema;Section-4.8"/>
				<cmns-qtu:hasNumericValue rdf:datatype="&xsd;positiveInteger">1</cmns-qtu:hasNumericValue>
			</cmns-strcol:IndexValue>
		</cmns-strcol:hasIndexValue>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.8-SummaryOfSafetyProfile-Paragraph-1">
		<rdf:type rdf:resource="&doco;Paragraph"/>
		<po:contains rdf:resource="&doc-ema;Section-4.8-SummaryOfSafetyProfile-Paragraph-1-Text"/>
		<cmns-strcol:hasIndexValue>
			<cmns-strcol:IndexValue>
				<cmns-doc:refersTo rdf:resource="&doc-ema;Section-4.8-SummaryOfSafetyProfile"/>
				<cmns-qtu:hasNumericValue rdf:datatype="&xsd;positiveInteger">1</cmns-qtu:hasNumericValue>
			</cmns-strcol:IndexValue>
		</cmns-strcol:hasIndexValue>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.8-SummaryOfSafetyProfile-Paragraph-1-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Unless otherwise stated, the frequency of listed adverse reactions is based on data from the VISION study in which 529 patients received at least one dose of 7 400 MBq (median number of doses was five).</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.8-SummaryOfSafetyProfile-Paragraph-2">
		<rdf:type rdf:resource="&doco;Paragraph"/>
		<po:contains rdf:resource="&doc-ema;Section-4.8-SummaryOfSafetyProfile-Paragraph-2-Text"/>
		<cmns-strcol:hasIndexValue>
			<cmns-strcol:IndexValue>
				<cmns-doc:refersTo rdf:resource="&doc-ema;Section-4.8-SummaryOfSafetyProfile"/>
				<cmns-qtu:hasNumericValue rdf:datatype="&xsd;positiveInteger">2</cmns-qtu:hasNumericValue>
			</cmns-strcol:IndexValue>
		</cmns-strcol:hasIndexValue>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.8-SummaryOfSafetyProfile-Paragraph-2-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>The most common adverse reactions include: fatigue (43.1%), dry mouth (39.3%), nausea (35.3%), anaemia (31.8%), decreased appetite (21.2%) and constipation (20.2%).
		The most common grade 3 to 4 adverse reactions include: anaemia (12.9%), thrombocytopenia (7.9%), lymphopenia (7.8%) and fatigue (5.9%).</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.8-SummaryOfSafetyProfile-Title">
		<rdf:type rdf:resource="&doco;SectionTitle"/>
		<idmp-doco:hasText>Summary of safety profile</idmp-doco:hasText>
		<idmp-doco:hasText>Tabulated list of adverse reactions</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.8-TabulatedListOfAdverseReactions">
		<rdf:type rdf:resource="&doco;Section"/>
		<po:contains rdf:resource="&doc-ema;Section-4.8-TabulatedListOfAdverseReactions-Text"/>
		<po:contains rdf:resource="&doc-ema;Table-2"/>
		<po:containsAsHeader rdf:resource="&doc-ema;Section-4.8-TabulatedListOfAdverseReactions-Title"/>
		<cmns-strcol:hasIndexValue>
			<cmns-strcol:IndexValue>
				<cmns-doc:refersTo rdf:resource="&doc-ema;Section-4.8"/>
				<cmns-qtu:hasNumericValue rdf:datatype="&xsd;positiveInteger">2</cmns-qtu:hasNumericValue>
			</cmns-strcol:IndexValue>
		</cmns-strcol:hasIndexValue>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.8-TabulatedListOfAdverseReactions-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Adverse reactions (Table 2) are listed by MedDRA system organ class. Within each system organ
class, the adverse reactions are ranked by frequency, with the most frequent reactions first. In addition,
the corresponding frequency category for each adverse reaction is based on the following convention
(CIOMS III): very common (â¥1/10); common (â¥1/100 to &lt;1/10); uncommon (â¥1/1 000 to &lt;1/100);
rare (â¥1/10 000 to &lt;1/1 000); very rare (&lt;1/10 000).</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.8-Title">
		<rdf:type rdf:resource="&doco;SectionTitle"/>
		<idmp-doco:hasText>Undesirable effects</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.9">
		<rdf:type rdf:resource="&doco;Section"/>
		<po:contains rdf:resource="&doc-ema;Section-4.9-Text"/>
		<po:containsAsHeader rdf:resource="&doc-ema;Section-4.9-Title"/>
		<cmns-strcol:hasIndexValue>
			<cmns-strcol:IndexValue>
				<cmns-doc:refersTo rdf:resource="&doc-ema;Section-4"/>
				<cmns-qtu:hasNumericValue rdf:datatype="&xsd;positiveInteger">9</cmns-qtu:hasNumericValue>
			</cmns-strcol:IndexValue>
		</cmns-strcol:hasIndexValue>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.9-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>In the event of administration of a radiation overdose with Pluvicto, the absorbed dose to the patient
should be reduced where possible by increasing the elimination of the radionuclide from the body by
frequent micturition or by forced diuresis and frequent bladder voiding. It might be helpful to estimate
the effective dose that was applied.</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-4.9-Title">
		<rdf:type rdf:resource="&doco;SectionTitle"/>
		<idmp-doco:hasText>Overdose</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-6">
		<rdf:type rdf:resource="&doco;Section"/>
		<po:contains rdf:resource="&doc-ema;Section-6.1"/>
		<po:contains rdf:resource="&doc-ema;Section-6.2"/>
		<po:contains rdf:resource="&doc-ema;Section-6.3"/>
		<po:contains rdf:resource="&doc-ema;Section-6.4"/>
		<po:containsAsHeader rdf:resource="&doc-ema;Section-6-Title"/>
		<cmns-strcol:hasIndexValue>
			<cmns-strcol:IndexValue>
				<cmns-doc:refersTo rdf:resource="&doc-ema;Annex-1"/>
				<cmns-qtu:hasNumericValue rdf:datatype="&xsd;positiveInteger">6</cmns-qtu:hasNumericValue>
			</cmns-strcol:IndexValue>
		</cmns-strcol:hasIndexValue>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-6-Title">
		<rdf:type rdf:resource="&doco;SectionTitle"/>
		<idmp-doco:hasText>Shelf life</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-6.1">
		<rdf:type rdf:resource="&doco;Section"/>
		<po:contains rdf:resource="&doc-ema;Section-6.1-Text"/>
		<po:containsAsHeader rdf:resource="&doc-ema;Section-6.1-Title"/>
		<cmns-strcol:hasIndexValue>
			<cmns-strcol:IndexValue>
				<cmns-doc:refersTo rdf:resource="&doc-ema;Section-6"/>
				<cmns-qtu:hasNumericValue rdf:datatype="&xsd;positiveInteger">1</cmns-qtu:hasNumericValue>
			</cmns-strcol:IndexValue>
		</cmns-strcol:hasIndexValue>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-6.1-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Acetic acid
Sodium acetate
Gentisic acid
Sodium ascorbate
Pentetic acid
Water for injections</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-6.1-Title">
		<rdf:type rdf:resource="&doco;SectionTitle"/>
		<idmp-doco:hasText>List of excipients</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-6.2">
		<rdf:type rdf:resource="&doco;Section"/>
		<po:contains rdf:resource="&doc-ema;Section-6.2-Text"/>
		<po:containsAsHeader rdf:resource="&doc-ema;Section-6.2-Title"/>
		<cmns-strcol:hasIndexValue>
			<cmns-strcol:IndexValue>
				<cmns-doc:refersTo rdf:resource="&doc-ema;Section-6"/>
				<cmns-qtu:hasNumericValue rdf:datatype="&xsd;positiveInteger">2</cmns-qtu:hasNumericValue>
			</cmns-strcol:IndexValue>
		</cmns-strcol:hasIndexValue>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-6.2-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>This medicinal product must not be mixed with other medicinal products except those mentioned in
sections 4.2 and 12.</idmp-doco:hasText>
		<cmns-doc:refersTo rdf:resource="&doc-ema;Section-12"/>
		<cmns-doc:refersTo rdf:resource="&doc-ema;Section-4.2"/>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-6.2-Title">
		<rdf:type rdf:resource="&doco;SectionTitle"/>
		<idmp-doco:hasText>Incompatibilities</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-6.3">
		<rdf:type rdf:resource="&doco;Section"/>
		<po:contains rdf:resource="&doc-ema;Section-6.3-Text"/>
		<po:containsAsHeader rdf:resource="&doc-ema;Section-6.3-Title"/>
		<cmns-strcol:hasIndexValue>
			<cmns-strcol:IndexValue>
				<cmns-doc:refersTo rdf:resource="&doc-ema;Section-6"/>
				<cmns-qtu:hasNumericValue rdf:datatype="&xsd;positiveInteger">3</cmns-qtu:hasNumericValue>
			</cmns-strcol:IndexValue>
		</cmns-strcol:hasIndexValue>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-6.3-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>120 hours (5 days) from the date and time of calibration.</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-6.3-Title">
		<rdf:type rdf:resource="&doco;SectionTitle"/>
		<idmp-doco:hasText>Shelf life</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-6.4">
		<rdf:type rdf:resource="&doco;Section"/>
		<po:contains rdf:resource="&doc-ema;Section-6.4-Text"/>
		<po:containsAsHeader rdf:resource="&doc-ema;Section-6.4-Title"/>
		<cmns-strcol:hasIndexValue>
			<cmns-strcol:IndexValue>
				<cmns-doc:refersTo rdf:resource="&doc-ema;Section-6"/>
				<cmns-qtu:hasNumericValue rdf:datatype="&xsd;positiveInteger">4</cmns-qtu:hasNumericValue>
			</cmns-strcol:IndexValue>
		</cmns-strcol:hasIndexValue>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-6.4-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Do not freeze.
Store in the original package in order to protect from ionising radiation (lead shielding).
Storage of radiopharmaceuticals should be in accordance with national regulations on radioactive
materials.</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-6.4-Title">
		<rdf:type rdf:resource="&doco;SectionTitle"/>
		<idmp-doco:hasText>Special precautions for storage</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-6.5">
		<rdf:type rdf:resource="&doco;Section"/>
		<po:contains rdf:resource="&doc-ema;Section-6.5-Text"/>
		<po:containsAsHeader rdf:resource="&doc-ema;Section-6.5-Title"/>
		<cmns-strcol:hasIndexValue>
			<cmns-strcol:IndexValue>
				<cmns-doc:refersTo rdf:resource="&doc-ema;Section-6"/>
				<cmns-qtu:hasNumericValue rdf:datatype="&xsd;positiveInteger">5</cmns-qtu:hasNumericValue>
			</cmns-strcol:IndexValue>
		</cmns-strcol:hasIndexValue>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-6.5-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Clear, colourless type I glass vial, closed with a bromobutyl rubber stopper and aluminium seal.
Each vial contains a volume of solution that can range from 7.5 mL to 12.5 mL corresponding to a
radioactivity of 7 400 MBq Â±10% at the date and time of administration.
The vial is enclosed within a lead container for protective shielding.</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-6.5-Title">
		<rdf:type rdf:resource="&doco;SectionTitle"/>
		<idmp-doco:hasText>Nature and contents of container</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-6.6">
		<rdf:type rdf:resource="&doco;Section"/>
		<po:contains rdf:resource="&doc-ema;Section-6.6-GeneralWarning"/>
		<po:containsAsHeader rdf:resource="&doc-ema;Section-6.6-Title"/>
		<cmns-strcol:hasIndexValue>
			<cmns-strcol:IndexValue>
				<cmns-doc:refersTo rdf:resource="&doc-ema;Section-6"/>
				<cmns-qtu:hasNumericValue rdf:datatype="&xsd;positiveInteger">6</cmns-qtu:hasNumericValue>
			</cmns-strcol:IndexValue>
		</cmns-strcol:hasIndexValue>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-6.6-GeneralWarning">
		<rdf:type rdf:resource="&doco;Section"/>
		<po:contains rdf:resource="&doc-ema;Section-6.6-GeneralWarning-Text"/>
		<po:containsAsHeader rdf:resource="&doc-ema;Section-6.6-GeneralWarning-Title"/>
		<cmns-strcol:hasIndexValue>
			<cmns-strcol:IndexValue>
				<cmns-doc:refersTo rdf:resource="&doc-ema;Section-6.6"/>
				<cmns-qtu:hasNumericValue rdf:datatype="&xsd;positiveInteger">1</cmns-qtu:hasNumericValue>
			</cmns-strcol:IndexValue>
		</cmns-strcol:hasIndexValue>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-6.6-GeneralWarning-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Radiopharmaceuticals should be received, used and administered only by authorised persons in
designated clinical settings. Their receipt, storage, use, transfer and disposal are subject to the
regulations and/or appropriate licences of the competent official organisation.
Radiopharmaceuticals should be prepared in a manner which satisfies both radiation safety and
pharmaceutical quality requirements. Appropriate aseptic precautions should be taken.
For instructions on preparation of the medicinal product before administration, see section 12.
If at any time in the preparation of this medicinal product the integrity of the lead container or the vial
is compromised it should not be used.
Administration procedures should be carried out in a way to minimise risk of contamination of the
medicinal product and irradiation of the operators. Adequate shielding is mandatory.
19
The administration of radiopharmaceuticals creates risks for other persons from external radiation or
contamination from spill of urine, vomiting, etc. Radiation protection precautions in accordance with
national regulations must therefore be taken.
This preparation is likely to result in a relatively high radiation dose to most patients. The
administration of Pluvicto may result in significant environmental hazard. This may be of concern to
the immediate family of those individuals undergoing treatment or the general public depending on the
level of activity administered. Suitable precautions in accordance with national regulations should be
taken concerning the activity eliminated by the patients in order to avoid any contaminations.
Lutetium-177 for Pluvicto may be prepared using two different sources of stable isotopes (either
lutetium-176 or ytterbium-176). Lutetium-177 for Pluvicto prepared using the stable isotope
lutetium-176 (âcarrier addedâ) requires special attention with regard to waste management due to the
presence of the long-lived metastable lutetium-177 (177mLu) impurity with a half-life of 160.4 days.
Lutetium-177 for Pluvicto is prepared using ytterbium-176 (ânon-carrier addedâ) unless otherwise
communicated on the product batch release certificate. The user must consult the product batch release
certificate provided before using Pluvicto to ensure appropriate waste management.
Any unused medicinal product or waste material should be disposed of in accordance with local
requirements.</idmp-doco:hasText>
		<cmns-doc:refersTo rdf:resource="&doc-ema;Section-12"/>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Section-6.6-Title">
		<rdf:type rdf:resource="&doco;SectionTitle"/>
		<idmp-doco:hasText>General warning</idmp-doco:hasText>
		<idmp-doco:hasText>Special precautions for disposal and other handling</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1">
		<rdf:type rdf:resource="&doco;Table"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Col-1"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Col-2"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Col-3"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Label"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-1"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-10"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-11"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-12"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-13"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-14"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-2"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-4"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-5"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-6"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-7"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-8"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-9"/>
		<idmp-doco:hasCaption rdf:resource="&doc-ema;Table-1-Caption"/>
		<cmns-strcol:hasIndexValue>
			<cmns-strcol:IndexValue>
				<cmns-doc:refersTo rdf:resource="&doc-ema;Annex-1"/>
				<cmns-qtu:hasNumericValue rdf:datatype="&xsd;positiveInteger">1</cmns-qtu:hasNumericValue>
			</cmns-strcol:IndexValue>
		</cmns-strcol:hasIndexValue>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Caption">
		<rdf:type rdf:resource="&idmp-doco;TableCaption"/>
		<idmp-doco:hasText>Recommended dose modifications of Pluvicto for adverse reactions</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Col-1">
		<rdf:type rdf:resource="&idmp-doco;TableColumn"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-2-Col-1"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-3-Col-1"/>
		<po:containsAsHeader rdf:resource="&doc-ema;Table-1-Row-1-Col-1"/>
		<idmp-doco:hasTableColumnIndex rdf:datatype="&xsd;positiveInteger">1</idmp-doco:hasTableColumnIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Col-2">
		<rdf:type rdf:resource="&idmp-doco;TableColumn"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-2-Col-2"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-3-Col-2"/>
		<po:containsAsHeader rdf:resource="&doc-ema;Table-1-Row-1-Col-2"/>
		<idmp-doco:hasTableColumnIndex rdf:datatype="&xsd;positiveInteger">2</idmp-doco:hasTableColumnIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Col-3">
		<rdf:type rdf:resource="&idmp-doco;TableColumn"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-2-Col-3"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-3-Col-3"/>
		<po:containsAsHeader rdf:resource="&doc-ema;Table-1-Row-1-Col-3"/>
		<idmp-doco:hasTableColumnIndex rdf:datatype="&xsd;positiveInteger">3</idmp-doco:hasTableColumnIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Label">
		<rdf:type rdf:resource="&doco;TableLabel"/>
		<idmp-doco:hasText>Table 1</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-1">
		<rdf:type rdf:resource="&idmp-doco;TableRow"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-1-Col-1"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-1-Col-2"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-1-Col-3"/>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">1</idmp-doco:hasTableRowIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-1-Col-1">
		<rdf:type rdf:resource="&idmp-doco;TableColumnHeaderCell"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-1-Col-1-Text"/>
		<idmp-doco:hasTableColumnIndex rdf:datatype="&xsd;positiveInteger">1</idmp-doco:hasTableColumnIndex>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">1</idmp-doco:hasTableRowIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-1-Col-1-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Adverse reaction</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-1-Col-2">
		<rdf:type rdf:resource="&idmp-doco;TableColumnHeaderCell"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-1-Col-2-Text"/>
		<idmp-doco:hasTableColumnIndex rdf:datatype="&xsd;positiveInteger">2</idmp-doco:hasTableColumnIndex>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">1</idmp-doco:hasTableRowIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-1-Col-2-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Severity</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-1-Col-3">
		<rdf:type rdf:resource="&idmp-doco;TableColumnHeaderCell"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-1-Col-3-Text"/>
		<idmp-doco:hasTableColumnIndex rdf:datatype="&xsd;positiveInteger">3</idmp-doco:hasTableColumnIndex>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">1</idmp-doco:hasTableRowIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-1-Col-3-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>&gt;Dose modification</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-10">
		<rdf:type rdf:resource="&idmp-doco;TableRow"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-10-Col-1"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-10-Col-2"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-10-Col-3"/>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">10</idmp-doco:hasTableRowIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-10-Col-1">
		<rdf:type rdf:resource="&idmp-doco;TableBodyCell"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-10-Col-1-Text"/>
		<idmp-doco:hasTableColumnIndex rdf:datatype="&xsd;positiveInteger">1</idmp-doco:hasTableColumnIndex>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">10</idmp-doco:hasTableRowIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-10-Col-1-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Fracture in weight-bearing bones</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-10-Col-2">
		<rdf:type rdf:resource="&idmp-doco;TableBodyCell"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-10-Col-2-Text"/>
		<idmp-doco:hasTableColumnIndex rdf:datatype="&xsd;positiveInteger">2</idmp-doco:hasTableColumnIndex>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">10</idmp-doco:hasTableRowIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-10-Col-2-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Any</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-10-Col-3">
		<rdf:type rdf:resource="&idmp-doco;TableBodyCell"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-10-Col-3-Text"/>
		<idmp-doco:hasTableColumnIndex rdf:datatype="&xsd;positiveInteger">3</idmp-doco:hasTableColumnIndex>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">10</idmp-doco:hasTableRowIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-10-Col-3-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Withhold Pluvicto until the fracture has been
adequately stabilised/treated and ECOG
performance status has stabilised.</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-11">
		<rdf:type rdf:resource="&idmp-doco;TableRow"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-11-Col-1"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-11-Col-2"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-11-Col-3"/>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">11</idmp-doco:hasTableRowIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-11-Col-1">
		<rdf:type rdf:resource="&idmp-doco;TableBodyCell"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-11-Col-1-Text"/>
		<idmp-doco:hasTableColumnIndex rdf:datatype="&xsd;positiveInteger">1</idmp-doco:hasTableColumnIndex>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">11</idmp-doco:hasTableRowIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-11-Col-1-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Fatigue</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-11-Col-2">
		<rdf:type rdf:resource="&idmp-doco;TableBodyCell"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-11-Col-2-Text"/>
		<idmp-doco:hasTableColumnIndex rdf:datatype="&xsd;positiveInteger">2</idmp-doco:hasTableColumnIndex>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">11</idmp-doco:hasTableRowIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-11-Col-2-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Grade â¥3</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-11-Col-3">
		<rdf:type rdf:resource="&idmp-doco;TableBodyCell"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-11-Col-3-Text"/>
		<idmp-doco:hasTableColumnIndex rdf:datatype="&xsd;positiveInteger">3</idmp-doco:hasTableColumnIndex>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">11</idmp-doco:hasTableRowIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-11-Col-3-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Withhold Pluvicto until improvement to Grade 2 or baseline.</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-12">
		<rdf:type rdf:resource="&idmp-doco;TableRow"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-12-Col-1"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-12-Col-2"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-12-Col-3"/>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">12</idmp-doco:hasTableRowIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-12-Col-1">
		<rdf:type rdf:resource="&idmp-doco;TableBodyCell"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-12-Col-1-Text"/>
		<idmp-doco:hasTableColumnIndex rdf:datatype="&xsd;positiveInteger">1</idmp-doco:hasTableColumnIndex>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">12</idmp-doco:hasTableRowIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-12-Col-1-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Electrolyte or metabolic abnormalities</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-12-Col-2">
		<rdf:type rdf:resource="&idmp-doco;TableBodyCell"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-12-Col-2-Text"/>
		<idmp-doco:hasTableColumnIndex rdf:datatype="&xsd;positiveInteger">2</idmp-doco:hasTableColumnIndex>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">12</idmp-doco:hasTableRowIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-12-Col-2-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Grade â¥2</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-12-Col-3">
		<rdf:type rdf:resource="&idmp-doco;TableBodyCell"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-12-Col-3-Text"/>
		<idmp-doco:hasTableColumnIndex rdf:datatype="&xsd;positiveInteger">3</idmp-doco:hasTableColumnIndex>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">12</idmp-doco:hasTableRowIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-12-Col-3-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Withhold Pluvicto until improvement to Grade 1 or baseline.</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-13">
		<rdf:type rdf:resource="&idmp-doco;TableRow"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-13-Col-1"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-13-Col-2"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-13-Col-3"/>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">13</idmp-doco:hasTableRowIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-13-Col-1">
		<rdf:type rdf:resource="&idmp-doco;TableBodyCell"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-13-Col-1-Text"/>
		<idmp-doco:hasTableColumnIndex rdf:datatype="&xsd;positiveInteger">1</idmp-doco:hasTableColumnIndex>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">13</idmp-doco:hasTableRowIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-13-Col-1-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Non-haematological toxicity (clinically significant, not otherwise stated)</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-13-Col-2">
		<rdf:type rdf:resource="&idmp-doco;TableBodyCell"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-13-Col-2-Text"/>
		<idmp-doco:hasTableColumnIndex rdf:datatype="&xsd;positiveInteger">2</idmp-doco:hasTableColumnIndex>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">13</idmp-doco:hasTableRowIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-13-Col-2-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Grade â¥2</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-13-Col-3">
		<rdf:type rdf:resource="&idmp-doco;TableBodyCell"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-13-Col-3-Text"/>
		<idmp-doco:hasTableColumnIndex rdf:datatype="&xsd;positiveInteger">3</idmp-doco:hasTableColumnIndex>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">13</idmp-doco:hasTableRowIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-13-Col-3-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Withhold Pluvicto until improvement to Grade 1 or baseline.</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-14">
		<rdf:type rdf:resource="&idmp-doco;TableRow"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-14-Col-1"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-14-Col-2"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-14-Col-3"/>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">14</idmp-doco:hasTableRowIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-14-Col-1">
		<rdf:type rdf:resource="&idmp-doco;TableBodyCell"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-14-Col-1-Text"/>
		<idmp-doco:hasTableColumnIndex rdf:datatype="&xsd;positiveInteger">1</idmp-doco:hasTableColumnIndex>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">14</idmp-doco:hasTableRowIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-14-Col-1-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>AST or ALT elevation</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-14-Col-2">
		<rdf:type rdf:resource="&idmp-doco;TableBodyCell"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-14-Col-2-Text"/>
		<idmp-doco:hasTableColumnIndex rdf:datatype="&xsd;positiveInteger">2</idmp-doco:hasTableColumnIndex>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">14</idmp-doco:hasTableRowIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-14-Col-2-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>AST or ALT &gt;5 times ULN in the absence of liver metastases</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-14-Col-3">
		<rdf:type rdf:resource="&idmp-doco;TableBodyCell"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-14-Col-3-Text"/>
		<idmp-doco:hasTableColumnIndex rdf:datatype="&xsd;positiveInteger">3</idmp-doco:hasTableColumnIndex>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">14</idmp-doco:hasTableRowIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-14-Col-3-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Permanently discontinue Pluvicto.</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-2">
		<rdf:type rdf:resource="&idmp-doco;TableRow"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-2-Col-1"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-2-Col-2"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-2-Col-3"/>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">2</idmp-doco:hasTableRowIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-2-Col-1">
		<rdf:type rdf:resource="&idmp-doco;TableBodyCell"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-2-Col-1-Text"/>
		<idmp-doco:hasTableColumnIndex rdf:datatype="&xsd;positiveInteger">1</idmp-doco:hasTableColumnIndex>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">2</idmp-doco:hasTableRowIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-2-Col-1-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Dry mouth</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-2-Col-2">
		<rdf:type rdf:resource="&idmp-doco;TableBodyCell"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-2-Col-2-Text"/>
		<idmp-doco:hasTableColumnIndex rdf:datatype="&xsd;positiveInteger">2</idmp-doco:hasTableColumnIndex>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">2</idmp-doco:hasTableRowIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-2-Col-2-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Grade 3</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-2-Col-3">
		<rdf:type rdf:resource="&idmp-doco;TableBodyCell"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-2-Col-3-Text"/>
		<idmp-doco:hasTableColumnIndex rdf:datatype="&xsd;positiveInteger">3</idmp-doco:hasTableColumnIndex>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">2</idmp-doco:hasTableRowIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-2-Col-3-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Reduce Pluvicto does by 20%.</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-3">
		<rdf:type rdf:resource="&idmp-doco;TableRow"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-3-Col-1"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-3-Col-2"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-3-Col-3"/>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">3</idmp-doco:hasTableRowIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-3-Col-1">
		<rdf:type rdf:resource="&idmp-doco;TableBodyCell"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-3-Col-1-Text"/>
		<idmp-doco:hasTableColumnIndex rdf:datatype="&xsd;positiveInteger">1</idmp-doco:hasTableColumnIndex>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">3</idmp-doco:hasTableRowIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-3-Col-1-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Gastrointestinal toxicity</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-3-Col-2">
		<rdf:type rdf:resource="&idmp-doco;TableBodyCell"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-3-Col-2-Text"/>
		<idmp-doco:hasTableColumnIndex rdf:datatype="&xsd;positiveInteger">2</idmp-doco:hasTableColumnIndex>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">3</idmp-doco:hasTableRowIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-3-Col-2-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Grade â¥3 (not amenable to medical intervention)</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-3-Col-3">
		<rdf:type rdf:resource="&idmp-doco;TableBodyCell"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-3-Col-3-Text"/>
		<idmp-doco:hasTableColumnIndex rdf:datatype="&xsd;positiveInteger">3</idmp-doco:hasTableColumnIndex>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">3</idmp-doco:hasTableRowIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-3-Col-3-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Withhold Pluvicto until improvement to grade 2 or baseline.
Reduce Pluvicto dose by 20%.</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-4">
		<rdf:type rdf:resource="&idmp-doco;TableRow"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-4-Col-1"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-4-Col-2"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-4-Col-3"/>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">4</idmp-doco:hasTableRowIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-4-Col-1">
		<rdf:type rdf:resource="&idmp-doco;TableBodyCell"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-4-Col-1-Text"/>
		<idmp-doco:hasTableColumnIndex rdf:datatype="&xsd;positiveInteger">1</idmp-doco:hasTableColumnIndex>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">4</idmp-doco:hasTableRowIndex>
		<idmp-doco:hasTableRowSpan rdf:datatype="&xsd;positiveInteger">2</idmp-doco:hasTableRowSpan>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-4-Col-1-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Anaemia,
thrombocytopenia,
leukopenia,
neutropenia,
pancytopenia</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-4-Col-2">
		<rdf:type rdf:resource="&idmp-doco;TableBodyCell"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-4-Col-2-Text"/>
		<idmp-doco:hasTableColumnIndex rdf:datatype="&xsd;positiveInteger">2</idmp-doco:hasTableColumnIndex>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">4</idmp-doco:hasTableRowIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-4-Col-2-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Grade 2</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-4-Col-3">
		<rdf:type rdf:resource="&idmp-doco;TableBodyCell"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-4-Col-3-Text"/>
		<idmp-doco:hasTableColumnIndex rdf:datatype="&xsd;positiveInteger">3</idmp-doco:hasTableColumnIndex>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">4</idmp-doco:hasTableRowIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-4-Col-3-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Withhold Pluvicto until improvement to
grade 1 or baseline.
Manage as deemed appropriate. The use of
growth factors is permitted but should be
discontinued once improved to grade 1 or
baseline. Checking haematinic levels (iron,
B12 and folate) and providing
supplementation is advocated. Transfusions
may be given as clinically indicated.</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-5">
		<rdf:type rdf:resource="&idmp-doco;TableRow"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-5-Col-2"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-5-Col-3"/>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">5</idmp-doco:hasTableRowIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-5-Col-2">
		<rdf:type rdf:resource="&idmp-doco;TableBodyCell"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-5-Col-2-Text"/>
		<idmp-doco:hasTableColumnIndex rdf:datatype="&xsd;positiveInteger">2</idmp-doco:hasTableColumnIndex>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">5</idmp-doco:hasTableRowIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-5-Col-2-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Grade â¥3</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-5-Col-3">
		<rdf:type rdf:resource="&idmp-doco;TableBodyCell"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-5-Col-3-Text"/>
		<idmp-doco:hasTableColumnIndex rdf:datatype="&xsd;positiveInteger">3</idmp-doco:hasTableColumnIndex>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">5</idmp-doco:hasTableRowIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-5-Col-3-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Withhold Pluvicto until improvement to
grade 1 or baseline.
Reduce Pluvicto dose by 20%.</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-6">
		<rdf:type rdf:resource="&idmp-doco;TableRow"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-6-Col-1"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-6-Col-2"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-6-Col-3"/>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">6</idmp-doco:hasTableRowIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-6-Col-1">
		<rdf:type rdf:resource="&idmp-doco;TableBodyCell"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-6-Col-1-Text"/>
		<idmp-doco:hasTableColumnIndex rdf:datatype="&xsd;positiveInteger">1</idmp-doco:hasTableColumnIndex>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">6</idmp-doco:hasTableRowIndex>
		<idmp-doco:hasTableRowSpan rdf:datatype="&xsd;positiveInteger">3</idmp-doco:hasTableRowSpan>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-6-Col-1-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Renal toxicity</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-6-Col-2">
		<rdf:type rdf:resource="&idmp-doco;TableBodyCell"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-6-Col-2-Text"/>
		<idmp-doco:hasTableColumnIndex rdf:datatype="&xsd;positiveInteger">2</idmp-doco:hasTableColumnIndex>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">6</idmp-doco:hasTableRowIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-6-Col-2-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Defined as:
â¢ Confirmed serum
creatinine increase
(grade â¥2)
â¢ Confirmed CLcr
&lt;50 mL/min; calculate
using Cockcroft-Gault
with actual body weight</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-6-Col-3">
		<rdf:type rdf:resource="&idmp-doco;TableBodyCell"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-6-Col-3-Text"/>
		<idmp-doco:hasTableColumnIndex rdf:datatype="&xsd;positiveInteger">3</idmp-doco:hasTableColumnIndex>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">6</idmp-doco:hasTableRowIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-6-Col-3-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Withhold Pluvicto until improvement.</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-7">
		<rdf:type rdf:resource="&idmp-doco;TableRow"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-7-Col-2"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-7-Col-3"/>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">7</idmp-doco:hasTableRowIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-7-Col-2">
		<rdf:type rdf:resource="&idmp-doco;TableBodyCell"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-7-Col-2-Text"/>
		<idmp-doco:hasTableColumnIndex rdf:datatype="&xsd;positiveInteger">2</idmp-doco:hasTableColumnIndex>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">7</idmp-doco:hasTableRowIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-7-Col-2-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Defined as:
â¢ Confirmed â¥40%
increase from baseline
serum creatinine
and
â¢ Confirmed &gt;40%
decrease from baseline
CLcr; calculate using
Cockcroft-Gault with
actual body weight</idmp-doco:hasText>
		<idmp-doco:hasText>Recurrent renal toxicity (grade â¥3)</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-7-Col-3">
		<rdf:type rdf:resource="&idmp-doco;TableBodyCell"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-7-Col-3-Text"/>
		<idmp-doco:hasTableColumnIndex rdf:datatype="&xsd;positiveInteger">3</idmp-doco:hasTableColumnIndex>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">7</idmp-doco:hasTableRowIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-7-Col-3-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Withhold Pluvicto until improvement or return to baseline.
Reduce Pluvicto dose by 20%.</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-8">
		<rdf:type rdf:resource="&idmp-doco;TableRow"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-8-Col-2"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-8-Col-3"/>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">8</idmp-doco:hasTableRowIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-8-Col-2">
		<rdf:type rdf:resource="&idmp-doco;TableBodyCell"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-7-Col-2-Text"/>
		<idmp-doco:hasTableColumnIndex rdf:datatype="&xsd;positiveInteger">2</idmp-doco:hasTableColumnIndex>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">8</idmp-doco:hasTableRowIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-8-Col-3">
		<rdf:type rdf:resource="&idmp-doco;TableBodyCell"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-8-Col-3-Text"/>
		<idmp-doco:hasTableColumnIndex rdf:datatype="&xsd;positiveInteger">3</idmp-doco:hasTableColumnIndex>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">8</idmp-doco:hasTableRowIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-8-Col-3-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Permanently discontinue Pluvicto.</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-9">
		<rdf:type rdf:resource="&idmp-doco;TableRow"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-9-Col-1"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-9-Col-2"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-9-Col-3"/>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">9</idmp-doco:hasTableRowIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-9-Col-1">
		<rdf:type rdf:resource="&idmp-doco;TableBodyCell"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-9-Col-1-Text"/>
		<idmp-doco:hasTableColumnIndex rdf:datatype="&xsd;positiveInteger">1</idmp-doco:hasTableColumnIndex>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">9</idmp-doco:hasTableRowIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-9-Col-1-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Spinal cord compression</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-9-Col-2">
		<rdf:type rdf:resource="&idmp-doco;TableBodyCell"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-9-Col-2-Text"/>
		<idmp-doco:hasTableColumnIndex rdf:datatype="&xsd;positiveInteger">2</idmp-doco:hasTableColumnIndex>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">9</idmp-doco:hasTableRowIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-9-Col-2-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Any</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-9-Col-3">
		<rdf:type rdf:resource="&idmp-doco;TableBodyCell"/>
		<po:contains rdf:resource="&doc-ema;Table-1-Row-9-Col-3-Text"/>
		<idmp-doco:hasTableColumnIndex rdf:datatype="&xsd;positiveInteger">3</idmp-doco:hasTableColumnIndex>
		<idmp-doco:hasTableRowIndex rdf:datatype="&xsd;positiveInteger">9</idmp-doco:hasTableRowIndex>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-1-Row-9-Col-3-Text">
		<rdf:type rdf:resource="&po;Textual"/>
		<idmp-doco:hasText>Withhold Pluvicto until the compression has
been adequately treated and any neurological
sequela have stabilised and ECOG
performance status has stabilised.</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-2">
		<rdf:type rdf:resource="&doco;Table"/>
		<po:contains rdf:resource="&doc-ema;Table-2-Label"/>
		<idmp-doco:hasCaption rdf:resource="&doc-ema;Table-2-Caption"/>
		<cmns-strcol:hasIndexValue>
			<cmns-strcol:IndexValue>
				<cmns-doc:refersTo rdf:resource="&doc-ema;Annex-1"/>
				<cmns-qtu:hasNumericValue rdf:datatype="&xsd;positiveInteger">2</cmns-qtu:hasNumericValue>
			</cmns-strcol:IndexValue>
		</cmns-strcol:hasIndexValue>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-2-Caption">
		<rdf:type rdf:resource="&idmp-doco;TableCaption"/>
		<idmp-doco:hasText>Adverse reactions occurring at a higher incidence in patients who received Pluvicto plus BSoC compared to BSoC alone in VISION</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-2-Label">
		<rdf:type rdf:resource="&doco;TableLabel"/>
		<idmp-doco:hasText>Table 2</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-3">
		<rdf:type rdf:resource="&doco;Table"/>
		<po:contains rdf:resource="&doc-ema;Table-3-Label"/>
		<idmp-doco:hasCaption rdf:resource="&doc-ema;Table-3-Caption"/>
		<cmns-strcol:hasIndexValue>
			<cmns-strcol:IndexValue>
				<cmns-doc:refersTo rdf:resource="&doc-ema;Annex-1"/>
				<cmns-qtu:hasNumericValue rdf:datatype="&xsd;positiveInteger">3</cmns-qtu:hasNumericValue>
			</cmns-strcol:IndexValue>
		</cmns-strcol:hasIndexValue>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-3-Caption">
		<rdf:type rdf:resource="&idmp-doco;TableCaption"/>
		<idmp-doco:hasText>Efficacy results in VISION</idmp-doco:hasText>
	</owl:NamedIndividual>
	
	<owl:NamedIndividual rdf:about="&doc-ema;Table-3-Label">
		<rdf:type rdf:resource="&doco;TableLabel"/>
		<idmp-doco:hasText>Table 3</idmp-doco:hasText>
	</owl:NamedIndividual>

</rdf:RDF>